NFKB1 and Parkinson disease: The DPP-4 inhibitor saxagliptin inhibited the decreased levels of DA neurons; cAMP, BDNF and BCL-2; and increased levels of NF-κB, TNF-α, iNOS, ICAM-1, and MPO in rotenone-induced PD rats [30].